Martin Plöderl Add us as a preferred source on Google
🔄 Data last refreshed 10 days ago
🤝
Make a deal with Martin Plöderl
🔒 Paid proposals held safely in escrow — released only when the work's approved.
Followers
231
Account age
2 yrs
💰 Suggested sponsorship rate
$40 – $65 / sponsored post
Estimated from audience size & typical reach — every deal is negotiable and held in SocialDB escrow.
🎁 Free analysisfor Martin Plöderl
📊 Post engagement
1
Avg engagement / post
0.4%
Engagement vs followers
Aug 2024
On Mastodon since
🔥 Top post: Our study on fluoxetine's loss of efficacy to treat pediatric de · 1 likes + reposts
📊 Activity & format
Posting cadence
0.22 / week
A lower-frequency account — each post lands with more weight.
Content mix
Mostly text
Recent: 8 text · 4 image · 0 video.
Follower / following
3×
Follows 76 back. A more reciprocal / networked account.
Recent posts
View on Mastodon ↗
🔥 Top post
Our study on fluoxetine's loss of efficacy to treat pediatric depression and the lack of acknowledgment of this finding in guidelines has been published.
https://www.jclinepi.com/article/S0895-4356(25)00349-X/fulltext
A longer thread can be found here:
https://bsky.app/profile…
Our new paper featured in Nature News
https://www.nature.com/articles/d41586-026-02769-x
Interested in learning how a small zombie-trial "infected" the body of evidence for fluoxetine to treat depression in children and adolecents?
Tomorrow, 2. February, 2:00–3:30pm (UK)
With @richlyus.bsky.social and me as presenters (via T…
Call for abstracts is open for the European Symposium on Suicide and Suicidal Behavior, ESSSB21 (Vilnius, 26-29 August 2026). Submit your symposium, workshop, oral, or poster by the deadlines. Details: https://www.esssb21.org/call-for-pap…
https://www.madinamerica.com/2025/10/a-call-for-evidence-based-fear-free-practice/
9. It was massive work. Big thanks to the team, and also Janssen who made their IPD available via YODA.
Thanks also to authors who supported us with additional data (I am convinced reaction by authors correlates with study quality).
8. Furthermore, the few trial where blinding was tested showed that blinding doesn't work well. In the few trials where ketemine was administered alongside an anesthetic procedure, the effect diminished. This suggests that the found short-…
7. Besides outcome switching, there are hints for problematic research practices in some trials. Some results just looked too good (no drop-out, effects sustained after weeks etc.). In one instance I contacted the journal bc there were sig…
6. In the risk of bias analyses, when checking the protocols or the entries on clinicaltrials.gov, we found many instances of outcome switching (check my timeline, I posted about this here for nearly all detected trials) and contacted the …
5. A striking finding: repeated doses were clearly not superior to single doses in the reduction of suicide ideation. This it at odds with the common practice of repeated doses. It was confirmed by another review which appeared after we co…
4. There was a larger reduction of suicide ideation in the first 3 days with ketamine/esketamine vs. placebo. This was found in previous reviews, too.
However, in subgroup analyses, we found that this applied to ketamine only. Esketamine'…
3. The results for suic behavior were inconclusive (the CI's overlapped with the null). Numerically, there were fewer suicide attempts with (es)ketamine arms vs. placebo, but there were numerically more suicides and deaths of any cause com…
Interested in learning how a small zombie-trial "infected" the body of evidence for fluoxetine to treat depression in children and adolecents?
Tomorrow, 2. February, 2:00–3:30pm (UK)
With @richlyus.bsky.social and me as presenters (via T…
Call for abstracts is open for the European Symposium on Suicide and Suicidal Behavior, ESSSB21 (Vilnius, 26-29 August 2026). Submit your symposium, workshop, oral, or poster by the deadlines. Details: https://www.esssb21.org/call-for-pap…
https://www.madinamerica.com/2025/10/a-call-for-evidence-based-fear-free-practice/
9. It was massive work. Big thanks to the team, and also Janssen who made their IPD available via YODA.
Thanks also to authors who supported us with additional data (I am convinced reaction by authors correlates with study quality).
8. Furthermore, the few trial where blinding was tested showed that blinding doesn't work well. In the few trials where ketemine was administered alongside an anesthetic procedure, the effect diminished. This suggests that the found short-…
7. Besides outcome switching, there are hints for problematic research practices in some trials. Some results just looked too good (no drop-out, effects sustained after weeks etc.). In one instance I contacted the journal bc there were sig…
6. In the risk of bias analyses, when checking the protocols or the entries on clinicaltrials.gov, we found many instances of outcome switching (check my timeline, I posted about this here for nearly all detected trials) and contacted the …
5. A striking finding: repeated doses were clearly not superior to single doses in the reduction of suicide ideation. This it at odds with the common practice of repeated doses. It was confirmed by another review which appeared after we co…
4. There was a larger reduction of suicide ideation in the first 3 days with ketamine/esketamine vs. placebo. This was found in previous reviews, too.
However, in subgroup analyses, we found that this applied to ketamine only. Esketamine'…
3. The results for suic behavior were inconclusive (the CI's overlapped with the null). Numerically, there were fewer suicide attempts with (es)ketamine arms vs. placebo, but there were numerically more suicides and deaths of any cause com…
🐘 Community & instance
Home server
fediscience.org
Their home server on the fediverse — the instance a creator picks signals the community they belong to.
On Mastodon since
Aug 2024
An established account with real history on the platform.
💡 Facts
🗓️Joined Mastodon in 2024 — 2 years ago.
👁️Averages 1 views per post.
📤Posts about 0.2× per week.
🕵️ Fake follower check
Estimated38/100
Low
Credibility score
68%
Mixed
Real audience
Medium
Fake-follower risk
High
Data confidence
- Est. 68% real, active audience · Medium fake-follower risk.
- Low engagement (~0.4% of followers engage each post) — a sign of an inflated or inactive audience.
Heuristic estimate from engagement, follower ratios, account age & growth — a screening signal, not a guarantee.
About
I love science, evidence based medicine, meta-science, R, cycling, nature. My research focus is suicide prevention, psychopharmacology, and keeping chicken.
📸 Gallery
🔀 Audience overlap
EstimatedEstimated shared audience with similar creators — useful for avoiding overlap (or doubling down) when planning a campaign.
Jayme
17%
Clemens Pitschke
16%
Ron Starman
16%
Jofish
14%
Xtrand
11%
Institute for Iranian Studies
11%
More like this
Find more →
Mastodon
＋
Clemens Pitschke ✓
@clemenspitschke@ecoevo.social
231
Followers
Mastodon
＋
Ron Starman ✓
@rstarman@infosec.exchange
231
Followers
Mastodon
＋
Xtrand
@mdx@hachyderm.io
231
Followers
Mastodon
＋
Jofish ✓
@jofish@hci.social
231
Followers
Mastodon
＋
Institute for Iranian Studies
@iranianstudies@hcommons.social
231
Followers
Mastodon
＋
Jayme ✓
@hippyjo@c.im
231
Followers
Frequently asked questions
How much does Martin Plöderl charge for a sponsorship?
Martin Plöderl hasn't published fixed prices yet. Send a proposal through SocialDB and agree terms directly — your payment is held in escrow until the work is approved.
How do I contact Martin Plöderl for a brand deal or collaboration?
Send a paid deal or collab request right here on SocialDB — we notify Martin Plöderl, and once they accept, your payment is held safely in escrow and released when the work is approved. You don't need to track down an email.
How many followers does Martin Plöderl have?
Martin Plöderl has 231 followers on Mastodon.
✉ Message Martin Plöderl
Reaching out to influencers is a Pro feature. Upgrade to message any influencer directly — perfect for brands and agencies booking sponsorships.
- ✓ Message any influencer from their listing
- ✓ The influencer gets notified by email
- ✓ Manage every conversation in one inbox
Already Pro? Log in.
🎤 Event / appearance with Martin Plöderl
Booking an event / appearance is a Pro feature. Upgrade to book Martin Plöderl for an in-person or virtual appearance — payment held safely in escrow until the event is done.
- ✓ Book them for events, livestreams, panels & more
- ✓ Martin Plöderl gets notified by email
- ✓ Fee held in escrow, released after the appearance
Already Pro? Log in.
🚀
You're out of free requests this month
Free accounts get 5 per month. Go Pro for unlimited sponsor pitches, collab requests & sponsorship deals — plus featured placement, the Verified badge, free withdrawals and more.
Upgrade to Pro — $9.95/mo →Your free limit resets on the 1st of next month.
Auto-generated from Mastodon's public data — no affiliation with or endorsement by SocialDB. Is this you? Claim it · Remove